Literature DB >> 10637432

Structure and function in the p53 family.

C H Arrowsmith1.   

Abstract

The recent discovery of several p53 homologs has uncovered a p53 superfamily of transcription factors that can trigger cell cycle arrest and apoptosis. The challenge now is to understand the similarities and differences between family members especially in terms of their regulation and potential for physical or genetic interactions with one another. This review summarizes recent progress in understanding the structure-function relationship within the p53 family. The new family members, p63 and p73, have an additional conserved domain at their C-termini which may have a regulatory function. The structure of this domain (a SAM domain) suggests that it is a protein-protein interaction module that may be involved in developmental processes. The oligomerization domains of p53 family members, while conserved in sequence and three-dimensional structure do not interact appreciably with other family members, but do mediate interactions between the multiple splice variants from an individual gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10637432     DOI: 10.1038/sj.cdd.4400619

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  28 in total

Review 1.  Utilizing NMR to study the structure of growth-inhibitory proteins.

Authors:  Francesca Marassi
Journal:  Methods Mol Biol       Date:  2003

2.  Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.

Authors:  Samir Benosman; Xiangjun Meng; Yannick Von Grabowiecki; Lavinia Palamiuc; Lucian Hritcu; Isabelle Gross; Georg Mellitzer; Yoichi Taya; Jean-Philippe Loeffler; Christian Gaiddon
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

3.  Study on the spatial architecture of p53, MDM2, and p14ARF containing complexes.

Authors:  Andrej Savchenko; Mariya Yurchenko; Boris Snopok; Elena Kashuba
Journal:  Mol Biotechnol       Date:  2008-11-07       Impact factor: 2.695

4.  Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer.

Authors:  B A Patrick; X Gong; A K Jaiswal
Journal:  Oncogene       Date:  2010-11-01       Impact factor: 9.867

5.  Crystal structures of the DNA-binding domain tetramer of the p53 tumor suppressor family member p73 bound to different full-site response elements.

Authors:  Abdul S Ethayathulla; H Thien Nguyen; Hector Viadiu
Journal:  J Biol Chem       Date:  2012-12-14       Impact factor: 5.157

6.  Peptide-protein interactions suggest that acetylation of lysines 381 and 382 of p53 is important for positive coactivator 4-p53 interaction.

Authors:  Subrata Debnath; Snehajyoti Chatterjee; Mohammed Arif; Tapas K Kundu; Siddhartha Roy
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

7.  Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.

Authors:  Hidetaka Uramoto; Hiroto Izumi; Gunji Nagatani; Haruki Ohmori; Naofumi Nagasue; Tomoko Ise; Takeshi Yoshida; Kosei Yasumoto; Kimitoshi Kohno
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

8.  Intrinsically disordered regions of p53 family are highly diversified in evolution.

Authors:  Bin Xue; Celeste J Brown; A Keith Dunker; Vladimir N Uversky
Journal:  Biochim Biophys Acta       Date:  2013-01-22

Review 9.  Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection.

Authors:  Martin B Wax; Gülgün Tezel
Journal:  Mol Neurobiol       Date:  2002-08       Impact factor: 5.590

Review 10.  Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.

Authors:  Li-Dong Wang; Shu Zheng; Zuo-Yu Zheng; Alan G Casson
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.